# Obesity/Nutrition
 
Obesity/Nutrition – Nina Hill

Background

-   BMI = Body Weight (kg) + Height (meters) squared
-   Overweight = BMI 25.0-29.9
-   Obesity:
    -   Class I 30-34.9
    -   Class II 35-39.9
    -   Class IIIA 40-44.9
    -   Class IIIB 45-49.9
    -   Class IIIC 50+

​​​​​​​​​​​​​​

Management

-   Goals: Target initial weight loss of 5-7% body weight, schedule
    frequent follow up to assess progress. Request pts send 48 hr food
    log. Encourage accountability “buddies.” Consider weight loss apps:
    My Fitness Pal, Lose it
-   Diet:
    -   Calorie
        restriction > macronutrient composition (e.g., low fat, low
        carb)
    -   Mediterranean
        : high in unsaturated fats, fruit/veg, legumes, grains; moderate
        dairy & EtOH; less meat (decreased overall mortality and CV
        mortality; may decrease diabetes incidence independent of weight
        loss)
    -   Dot phrases
        below for pictoral representation of cultural diets adapted to
        fit Mediterranean guidelines (Asian, African, Latin American)
-   DASH
    : High in fruits/vegetables, moderate dairy, \< 25% caloric intake
    from fat (decreases SBP/DBP)
-   Exercise: >30 min, 5-7 days per week, ideally a combo of aerobic +
    resistance training.
    -   ​​​​​​​
        Exercise alone is not sufficient for weight loss.
    -   Medications: If BMI
        ≥30 or
        BMI ≥27 with
        ≥1 comorbidity. Significant short term weight loss (\~ 5-15
        lbs), but weight is typically gained back when stopped
-   Referral to medical weight loss: If BMI
    ≥ 30
    or BMI
    ≥27
    with comorbid conditions (fatty liver disease, diabetes mellitus,
    HTN, OSA)
-   Referral to surgical weight loss: If BMI
    ≥40
    or BMI
    ≥35
    with comorbid conditions

​​​​​​​

| 0                               | 1                                                                                                                                                        | 2                                                                                                                |
|---------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|
| Medication                      | Mechanism                                                                                                                                                | Common Side Effects                                                                                              |
| Orlistat (Xenical)              | Reduces fat adsorption                                                                                                                                   | Diarrhea, gas, leakage of oily stools, stomach pain                                                              |
| Phentermine-topiramate (Qsymia) | Phentermine: appetite suppression Topiramate (anticonvulsant, migraine txt): ?appetite suppression, ?altered satiety perception                          | Constipation, dizziness, dry mouth, taste changes, tingling of hands and feet, insomnia                          |
| Naltrexone-bupropion (Contrave) | Naltrexone (partial opioid antagonist; used for alcohol dependence): ?altered satiety perception Bupropion (antidepressant): ?altered satiety perception | Constipation, diarrhea, dizziness, dry mouth, headache, BP, tachycardia, insomnia, liver damage, nausea/vomiting |
| Liraglutide (Saxenda)           | Appetite suppression; quickens satiety (Victoza: lower dose formulation, FDA-approved for T2DM)                                                          | Nausea, diarrhea, constipation, abdominal pain, headache, tachycardia                                            |
| Phentermine (Ionamin)           | Reduces appetite Note: FDA-approved only for short-term use—up to 12 weeks                                                                               | Dry mouth, constipation, insomnia, dizziness, nervousness/ restlessness headache, HTN, tachycardia               |
| Semaglutide (Ozempic/Rybelsus)  | Glucagon-like peptide-1 receptor agonist; reduces appetite                                                                                               | Nausea, vomiting, diarrhea, abdominal pain, constipation                                                         |
